REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 27th, 2017 • Rich Pharmaceuticals, Inc. • Pharmaceutical preparations • Nevada
This REGISTRATION RIGHTS AGREEMENT (the “Agreement”), dated as of February 22, 2017 (the “Execution Date”), is entered into by and between Rich Pharmaceuticals, Inc., a Nevada corporation with its principal executive office at 9595 Wilshire Boulevard, Suite 900, Beverly Hills, CA 90212 (the “Company”), and GHS Investments LLC, a Nevada limited liability company, with offices at 200 Stonehinge Lane, Suite 3, Carle Place, NY 11514. (the “Investor”).
EQUITY FINANCING AGREEMENTEquity Financing Agreement • February 27th, 2017 • Rich Pharmaceuticals, Inc. • Pharmaceutical preparations • Nevada
This EQUITY FINANCING AGREEMENT (the “Agreement”), dated as of February 22, 2017 (the “Execution Date”), is entered into by and between Rich Pharmaceuticals, Inc., a Nevada corporation with its principal executive office at 9595 Wilshire Boulevard, Suite 900 Beverly Hills, CA 90212 (the “Company”), and GHS Investments LLC, a Nevada limited liability company, with offices at 200 Stonehinge Lane, Suite 3, Carle Place, NY 11514. (the “Investor”).
DEBT PURCHASE AGREEMENTDebt Purchase Agreement • February 27th, 2017 • Rich Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Debt Purchase Agreement (the “Agreement”) made as of this _17th day of February, 2017 by and between LG Capital Funding, LLC (the “Seller”) and GHS Investments, LLC (the “Buyer”).
